Renovus Capital Partners (“Renovus”), a Philadelphia-area buyout firm focused on founder-owned businesses in the Knowledge & Talent industries, announces that it has closed its first multi-asset continuation fund (“Renovus Continuation Fund” or “CV”) of approximately $325 million. The new fund was formed to recapitalize four portfolio companies from Renovus Capital Partners, LP (“Fund I”) and Renovus Capital Partners II, LP (“Fund II”). The four companies in the Renovus Continuation Fund (“CV Portfolio”) include ClinicalMind, a New York based full-service medical communication company specializing in scientific content development, strategic communications and technology solutions engaged by leading life sciences companies to help educate healthcare professionals about new and existing drugs.
Read the full article: Renovus Capital Partners Announces the Successful Close of a $325M Continuation Fund to Support the Exit and Future Growth of Four Portfolio Companies //
Source: https://renovuscapital.com/renovus-capital-partners-announces-the-successful-close-of-a-325-million-continuation-fund-to-support-the-exit-and-future-growth-of-four-portfolio-companies